Moreover, PGD2 inhibits tumor angiogenesis and promotes tumor cell necrosis by downregulating the expression of vascular endothelial growth factor (VEGF) as well as its receptors FLT-1 and FLK/KDR. This evidence concerns the gene VEGFA and neoplasm.